| Trial Identifier: | D1690R00044 |
| Sponsor: | AstraZeneca |
| NCTID: | NCT03549754 |
| Start Date: | February 2018 |
| Primary Completion Date: | December 2025 |
| Study Completion Date: | December 2025 |
| Condition: | Chronic Kidney Diseases; Congestive Heart Failure; Diabetes: Type 2; Hypertension |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| Costa Rica, Los Yoses, San Pedro | San Jose, Los Yoses, San Pedro, Costa Rica, 11501 |
| Egypt, Cairo | Haram, Cairo, Egypt, NA |
| Egypt, Cairo | Haram, Cairo, Egypt, NA |
| Egypt, Alexandria | Fleming, Alexandria, Egypt, NA |
| Egypt, Assiut | downtown, Assiut, Egypt, NA |
| India | Delhi, India, 110063 |
| India | Pondicherry, India, 605014 |
| India | Vadodara, India, 390023 |
| Malaysia, Iskandar Puteri | Johor Darul Takzim, Iskandar Puteri, Malaysia, 79250 |
| Mexico, Jalisco | Guadalajara, Jalisco, Mexico, 44600 |
| Mexico, Jalisco | Guadalajara, Jalisco, Mexico, 44340 |
| Mexico, Jalisco | Guadalajara, Jalisco, Mexico, 44670 |
| Mexico, Queretaro | San Juan del Rio, Queretaro, Mexico, 76800 |
| Mexico, Chihuahua | Chihuahua, Mexico, 31217 |
| Mexico, Nuevo Leon | Monterrey, Nuevo Leon, Mexico, 64460 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2023 Pharma Intelligence UK Limited (Citeline), a Norstella company